Resignation of Dr. Simrat Sohal as Compliance officer of the Company
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Simrat Sohal, Compliance Officer and Senior Management Personnel of GlaxoSmithKline Pharmaceuticals, has tendered her resignation effective close of business hours on 5th August 2026. She is leaving to pursue opportunities outside the Company. The resignation was submitted on 19th May 2026 and formally disclosed to the stock exchanges on 29th May 2026. The Company has confirmed her alignment with the proposed final working date and noted her commitment to ensuring a smooth transition and completing handover responsibilities during the notice period.
The departure of a Compliance Officer represents a key managerial change. Shareholders should monitor for the appointment of a replacement to ensure regulatory compliance obligations remain fulfilled. This is a routine but notable KMP transition.